Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
DMII
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
finance.yahoo.comPOSITIVO
NexGen Energy’s Rook I Project Emerges as a Key Source in the Next Uranium Supply Wave
What happened According to a February 9, 2026, SEC filing, MMCAP International Inc. SPC increased its position in NexGen Energy Ltd.(NYSE:NXE) by 2,379,891 shares during the fourth quarter of 2025. The estimated transaction value was appro…
Drugs Made In America Acquisition II Corp. Announces the Separate Trading of its Ordinary Shares and Rights Commencing December 3, 2025
Fort Lauderdale, FL, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Drugs Made In America Acquisition II Corp. (the “Company”), a special purpose acquisition company formed as a Cayman Islands exempted company, today announced that commencing December…
Families of Trump and commerce secretary stand to benefit from U.S. drug overhaul: WSJ
[President Trump Signs Executive Order At The White House] Andrew Harnik/Getty Images News Family members of President Donald Trump and Commerce Secretary Howard Lutnick are set to profit as the U.S. government steps up its efforts to lowe…
Drugs Made In America Acquisition II Corp. Announces Closing of $500,000,000 Initial Public Offering
Fort Lauderdale, FL, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Drugs Made In America Acquisition II Corp. (Nasdaq: DMIIU) (the “Company”) today announced that it closed its initial public offering of 50,000,000 units at $10.00 per unit. The gross…
Drugs Made In America Acquisition II Corp. Announces Closing of $500,000,000 Initial Public Offering
Fort Lauderdale, FL, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Drugs Made In America Acquisition II Corp. (Nasdaq: DMIIU) (the “Company”) today announced that it closed its initial public offering of 50,000,000 units at $10.00 per unit. The gross…
Drugs Made In America Acquisition II Corp. Announces Pricing of $500,000,000 Initial Public Offering
Fort Lauderdale, FL, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Drugs Made In America Acquisition II Corp. (Nasdaq: DMIIU) (the “Company”) announced today the pricing yesterday of its initial public offering of 50,000,000 units at $10.00 per unit.…
Drugs Made In America Acquisition II Corp. Announces Pricing of $500,000,000 Initial Public Offering
Fort Lauderdale, FL, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Drugs Made In America Acquisition II Corp. (Nasdaq: DMIIU) (the “Company”) announced today the pricing yesterday of its initial public offering of 50,000,000 units at $10.00 per unit.…